Skip to main content
All lobbying filings

ARENTFOX SCHIFF LLP

Lobbying for TRANSPARENCY-RX CORP. · Coalition of licensed transparent pharmacy benefit managers

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$20,000.00
What the client paid this registrant for the period.
Client based in
Virginia

Official filing document

 Lobbyists on this filing 1
  • KELSEY GRISWOLD-BERGER New on this filing
    Previously held: Sr Policy Advisor, Sen McCormick (2025); LA, Sen Burr (2021-23); Leg Dir, Rep C Smith (2018-21); Leg Dir, Rep Pittenger (2018); Leg Dir, Rep Blum (2017-18); LA, Rep Perry (2015-17); LA (2014-15), LC/Press Asst (2011-14), SA (2011), Rep Reed

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 5
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • Labor, Dept of (DOL)
  • Office of Management & Budget (OMB)
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 2
 Lobbying activity 1
Health Issues

Pharmacy Benefit Manager Reform Transparency in prescription drug markets Prescription drug prices S. 891 (Bipartisan Health Care Act), regarding Pharmacy Benefit Manager reform, transparency in prescription drug markets, and prescription drug prices H.R. 4317 (PBM Reform Act of 2025), regarding Pharmacy Benefit Manager reform, transparency in prescription drug markets, and prescription drug prices

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem